Moderate SCRIB Expression Levels Correlate with Worse Prognosis in OPSCC Patients Regardless of HPV Status
Cells · 2024
DOI: 10.3390/cells13121002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Lucija Lulić und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Tumor Suppressor Proteins, Membrane Proteins. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science fundation, ICGEB, Croatian Science Foundation.
Abstract (Originalsprache)
Head and neck cancers rank as the sixth most prevalent cancers globally. In addition to traditional risk factors such as smoking and alcohol use, human papillomavirus (HPV) infections are becoming a significant causative agent of head and neck cancers, particularly among Western populations. Although HPV offers a significant survival benefit, the search for better biomarkers is still ongoing. In the current study, our objective was to investigate whether the expression levels of three PDZ-domain-containing proteins (SCRIB, NHERF2, and DLG1), known HPV E6 cellular substrates, influence the survival of HNSCC patients treated by primary surgery (n = 48). Samples were derived from oropharyngeal and oral cancers, and HPV presence was confirmed by PCR and p16 staining. Clinical and follow-up information was obtained from the hospital database and the Croatian Cancer registry up to November 2023. Survival was evaluated using the Kaplan–Meier method and Cox proportional hazard regression. The results were corroborated through the reanalysis of a comparable subset of TCGA cancer patients (n = 391). In conclusion, of the three targets studied, only SCRIB levels were found to be an independent predictor of survival in the Cox regression analysis, along with tumor stage. Further studies in a more typical Western population setting are needed since smoking and alcohol consumption are still prominent in the Croatian population, while the strongest association between survival and SCRIB levels was seen in HPV-negative cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.
- Division of Molecular Biology, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.
- Department of Pathology and Cytology, University Hospital Dubrava, 10000 Zagreb, Croatia.
- Department of Maxillofacial Surgery, University Hospital Dubrava, 10000 Zagreb, Croatia.
ORCID-Profile: Lucija Lulić, Ivana Šimić, Ksenija Božinović, Ena Pešut, Luka Manojlović, Magdalena Grce, Ivan Sabol
Förderung
- Croatian Science fundation
- ICGEB
- Croatian Science Foundation
- ICGEB Early Career Return
Zitieren
APA
Lulić, L., Šimić, I., Božinović, K., Pešut, E., Manojlović, L., Grce, M., Dediol, E., Sabol, I., & Tomaić, V. (2024). Moderate SCRIB Expression Levels Correlate with Worse Prognosis in OPSCC Patients Regardless of HPV Status. Cells. https://doi.org/10.3390/cells13121002
Vancouver
Lulić L, Šimić I, Božinović K, Pešut E, Manojlović L, Grce M, et al. Moderate SCRIB Expression Levels Correlate with Worse Prognosis in OPSCC Patients Regardless of HPV Status. Cells. 2024. doi:10.3390/cells13121002
BibTeX
@article{Luli2024,
author = {Lulić, Lucija and Šimić, Ivana and Božinović, Ksenija and Pešut, Ena and Manojlović, Luka and Grce, Magdalena and Dediol, Emil and Sabol, Ivan and Tomaić, Vjekoslav},
title = {Moderate SCRIB Expression Levels Correlate with Worse Prognosis in OPSCC Patients Regardless of HPV Status},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13121002}
}
EUVIMED